000 01417nas  2200313zi 4500
0019.939424
003CaOODSP
00520240618113626
006m     o  d f      
007cr cn ||||||||
008240617c20169999oncar p o    f0###a0eng d
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aH79-21E-PDF
1101 |aCanada. |bPatented Medicine Prices Review Board, |eauthor, |eissuing body.
24510|aFuture-oriented statement of operations (unaudited) for the year ending March 31 ... (in dollars) / |cPatented Medicine Prices Review Board.
264 1|a[Ottawa] : |b[Patented Medicine Prices Review Board], |c[2015]-
310 |aAnnual
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
3621 |aBegan with: 2015/2016.
500 |aIssued also in French under title: État des résultats prospectif (non audité) pour l'exercice terminé le 31 mars ... (en dollars).
588 |aDescription based on: 2015/2016.
588 |aLatest issue consulted: 2024/2025.
61010|aCanada. |bPatented Medicine Prices Review Board |xAppropriations and expenditures |vPeriodicals.
650 0|aFinance, Public|zCanada|xForecasting|vPeriodicals.
655 7|aPeriodicals|2lcgft
77508|tÉtat des résultats prospectif (non audité) pour l'exercice terminé le 31 mars ... (en dollars) / |w(CaOODSP)9.939433